手術防沾黏屏障市場:管道報告(發展階段、細分市場、地區/國家、監管途徑、主要參與者),2023 年最新版
市場調查報告書
商品編碼
1405127

手術防沾黏屏障市場:管道報告(發展階段、細分市場、地區/國家、監管途徑、主要參與者),2023 年最新版

Surgical Adhesion Barriers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

出版日期: | 出版商: GlobalData | 英文 66 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

沾黏是疤痕樣組織帶,形成異常纖維連接,在異常位置連接組織表面。一般來說,任何類型的經腹膜手術都可能導致沾黏的形成,從漿膜表面的最小疤痕到幾乎任何結構的牢固聚集。

本報告調查了手術沾黏屏障市場,並提供了產品概述、正在開發的管道產品趨勢、不同開發階段產品的比較分析、正在進行的臨床試驗資訊以及參與公司的最新趨勢等。

目錄

第一章 內容

第 2 章 簡介

第三章 開發中產品

  • 手術防沾黏屏障 - 按開發階段劃分的管道產品
  • 外科防沾黏屏障 - 按細分市場劃分的管道產品
  • 手術防沾黏屏障 - 區域管道產品
  • 外科防沾黏屏障 - 按監管途徑分類的管道產品
  • 外科防沾黏屏障 - 管道產品(按預計批准日期)
  • 手術防沾黏屏障 - 正在進行的臨床試驗

第4章:手術防沾黏屏障-公司正在開發的管道產品

  • 手術沾黏屏障公司 - 按開發階段劃分的管道產品
  • 手術防沾黏屏障 - 按開發階段劃分的管道產品

第五章 手術防沾黏屏障公司及產品概述

第六章 手術沾黏預防屏障 - 最新進展

第7章附錄

Abstract

GlobalData's Medical Devices sector report, "Surgical Adhesion Barriers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Surgical Adhesion Barriers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Adhesions are bands of scar-like tissue that forms abnormal fibrous connections joining tissue surfaces in abnormal locations. In general, any type of transperitoneal operation can lead to the formation of adhesions ranging from minimal scarring of serosal surface to firm agglutination of nearly all structures.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Surgical Adhesion Barriers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Surgical Adhesion Barriers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Surgical Adhesion Barriers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Surgical Adhesion Barriers Overview

3 Products under Development

  • 3.1 Surgical Adhesion Barriers - Pipeline Products by Stage of Development
  • 3.2 Surgical Adhesion Barriers - Pipeline Products by Segment
  • 3.3 Surgical Adhesion Barriers - Pipeline Products by Territory
  • 3.4 Surgical Adhesion Barriers - Pipeline Products by Regulatory Path
  • 3.5 Surgical Adhesion Barriers - Pipeline Products by Estimated Approval Date
  • 3.6 Surgical Adhesion Barriers - Ongoing Clinical Trials

4 Surgical Adhesion Barriers - Pipeline Products under Development by Companies

  • 4.1 Surgical Adhesion Barriers Companies - Pipeline Products by Stage of Development
  • 4.2 Surgical Adhesion Barriers - Pipeline Products by Stage of Development

5 Surgical Adhesion Barriers Companies and Product Overview

6 Surgical Adhesion Barriers- Recent Developments

  • 6.1 Jul 21, 2023: Seikagaku Announces Favorable Results From A Pivotal Study for Si-449, an Adhesion Barrier
  • 6.2 Jun 28, 2023: Medline Announces Leadership Transition Naming New CEO and President & COO
  • 6.3 May 17, 2023: S2Medical AB (publ) signs a distribution agreement for the Iranian market
  • 6.4 Apr 13, 2023: S2Medical AB (publ) signs a distributor agreement in the United Arab Emirates and delivers a record order of the skin substitute Epiprotect worth about SEK 2 million

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Surgical Adhesion Barriers - Pipeline Products by Stage of Development
  • Surgical Adhesion Barriers - Pipeline Products by Segment
  • Surgical Adhesion Barriers - Pipeline Products by Territory
  • Surgical Adhesion Barriers - Pipeline Products by Regulatory Path
  • Surgical Adhesion Barriers - Pipeline Products by Estimated Approval Date
  • Surgical Adhesion Barriers - Ongoing Clinical Trials
  • Surgical Adhesion Barriers Companies - Pipeline Products by Stage of Development
  • Surgical Adhesion Barriers - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Surgical Adhesion Barriers - Pipeline Products by Stage of Development
  • Surgical Adhesion Barriers - Pipeline Products by Segment
  • Surgical Adhesion Barriers - Pipeline Products by Territory
  • Surgical Adhesion Barriers - Pipeline Products by Regulatory Path
  • Surgical Adhesion Barriers - Pipeline Products by Estimated Approval Date
  • Surgical Adhesion Barriers - Ongoing Clinical Trials